Join leaders from East and West on the 28th & 29th of June in London to discuss how the pricing laws, approval process and operational challenges compare between Japan and European countries, and debate how the international competitive drive is opening and harmonising the different markets. In this meeting you will be able to:

• Contrast the opinions of speakers from leading Japanese and Western pharmaceutical companies such as Eisai, Pfizer and Kowa
• Discuss differences in the regulatory environment with public and industry experts from organisations such as EMEA or the ABPI
• Evaluate commercialisation challenges and investment trends with business development leaders from Tanaka Business School and GlaxoSmithKline
• Debate operational strategies in Japan and Europe

For more information, please email wendy_fanner@osneymedia.co.uk for an event PDF.

£1499 + VAT per person